PDS Biotechnology Corp(PDSB)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
PDSB has no upcoming report date in the calendar yet. It last reported on Nov 13, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±9.3%).
Did the stock rise after good news?
The next-day move after each of its last 8 EPS beats and 2 misses.
In plain words: it beat expectations 8 times, but the stock still fell 4 of those 8 times.
- Nov '26Missed▼ -10.9%
- May '26Beat▲ +20.9%
- Aug '25Beat▼ -5.7%
- May '25Beat▲ +3.1%
- Mar '25Beat▲ +0.8%
- Nov '24Missed▼ -18.3%
- Aug '24Beat▼ 0.0%
- May '24Beat▼ -1.0%
- Mar '24Beat▼ -14.1%
- Nov '23Beat▲ +18.6%
Clear beats and misses with a known reaction only. What counts as a beat
Why did PDSB fall after beating earnings?
3 of PDSB's last 10 reactions went against the EPS result. What stands out in each:
PDSB beat EPS estimates in 8 quarters, and the stock still closed lower the next day 3 times. In 2 of the 3 where we have price data, the stock had already run up before the report.
- Aug 13, 2025EPS beat +8.7%stock -5.7% next day
- It had risen 5.1% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.4% higher, but sellers took over and it closed -5.7%.
- May 15, 2024EPS beat +16.7%stock -1.0% next day
- It had risen 26.3% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 5.2% higher, but sellers took over and it closed -1.0%.
- Mar 27, 2024EPS beat +16.7%stock -14.1% next day
- It opened 10.7% lower as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was PDSB's earnings move already priced in?
PDSB's move in the month before each of its last 10 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 10 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does PDSB hold its opening gap after earnings?
PDSB's opening move after each report and where it closed that day.
In 8 reports PDSB opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 8 times (50%), and fully reversed 3 times. Gaps up faded 4 of 6; gaps down recovered 0 of 2.
- Nov 13, 2026ReversedOpened +1.0%, closed -10.9%
- Aug 13, 2025ReversedOpened +2.4%, closed -5.7%
- May 14, 2025HeldOpened +3.9%, closed +3.1%
- Mar 27, 2025FadedOpened +2.4%, closed +0.8%
- Nov 14, 2024HeldOpened -20.1%, closed -18.3%
- May 15, 2024ReversedOpened +5.2%, closed -1.0%
- Mar 27, 2024HeldOpened -10.7%, closed -14.1%
- Nov 14, 2023HeldOpened +6.6%, closed +18.6%
PDSB earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Before open | -$0.09 | -$0.11 | -22.2% | -10.92% | — |
| May 13, 2026 | Before open | -$0.14 | -$0.13 | +7.1% | +20.91% | +21.82% |
| Mar 30, 2026 | Before open | -$0.20 | -$0.14 | +30.0% | — | — |
| Nov 13, 2025 | After close | -$0.20 | -$0.19 | +5.0% | — | — |
| Aug 13, 2025 | Before open | -$0.23 | -$0.21 | +8.7% | -5.69% | -3.25% |
| May 14, 2025 | Before open | -$0.25 | -$0.21 | +16.0% | +3.15% | +11.81% |
| Mar 27, 2025 | Before open | -$0.28 | -$0.21 | +25.0% | +0.81% | -4.03% |
| Nov 14, 2024 | Before open | -$0.28 | -$0.29 | -3.6% | -18.33% | -27.40% |
| Aug 13, 2024 | Before open | -$0.33 | -$0.23 | +30.3% | 0.00% | +5.90% |
| May 15, 2024 | Before open | -$0.36 | -$0.30 | +16.7% | -0.99% | -1.27% |
| Mar 27, 2024 | Before open | -$0.42 | -$0.35 | +16.7% | -14.06% | -10.27% |
| Nov 14, 2023 | Before open | -$0.47 | -$0.35 | +25.5% | +18.55% | +25.21% |
PDSB Earnings FAQ
Answers computed from PDS Biotechnology Corp's reported history
PDSB has no upcoming report date in the calendar yet. It last reported on Nov 13, 2026; companies usually report every three months.
Over the last 12 quarters with a usable EPS surprise, PDSB beat the consensus estimate 10 times (83%), missed 2 and landed in line 0.
Across its last 10 quarters with a measured reaction, PDSB moved an average of ±9.3% in the first session after reporting. It closed higher 40% of the time; the largest gain was 20.9% and the largest drop -18.3%.
PDSB fell in the first session after 3 of its last 8 EPS beats (38%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 10 quarters with price data, PDSB moved an average of -4.3% in the 20 trading sessions before reporting and was higher in 50% of them. After a run-up of 3% or more (5 quarters), it fell the next day 40% of the time, averaging +7.2%. After a drop of 3% or more (5 quarters), it rose the next day 20% of the time, averaging -8.5%. This describes past reports; it is not a forecast.
In 8 reports PDSB opened at least 1% away from the previous close. It gave back half or more of that gap by the close 4 of 8 times (50%), and fully reversed 3 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · PDSB: 12 reported quarters, latest Nov 13, 2026. Information only, not investment advice.
Looking for more on PDSB?
Price charts, forecast, fundamentals and risk pages for PDSB are not on Tickzen yet. You can run a full stock analysis now.
Run the PDSB Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun